A Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease

Volume: 128, Issue: 8, Pages: 1125 - 1128
Published: Aug 1, 2021
Abstract
The arrival of teprotumumab has been hailed as a game-changer in the treatment of thyroid eye disease (TED).1Patel A. Yang H. Douglas R.S. A new era in the treatment of thyroid eye disease.Am J Ophthalmol. 2019; 208: 281-288Abstract Full Text Full Text PDF PubMed Scopus (18) Google Scholar This monoclonal antibody to the insulin-like growth factor-1 receptor is the first Food and Drug Administration (FDA)-approved treatment for TED.2Food and...
Paper Details
Title
A Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease
Published Date
Aug 1, 2021
Volume
128
Issue
8
Pages
1125 - 1128
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.